Back
Sep 27
Education
PRO 07 - Indolent Lymphomas: Radiation Oncology Considerations
MODERATOR(S)
Sanjeev Aggarwal, MD - UVA Health Cancer Center
session DESCRIPTION
Recent studies have led to radical change in concepts when considering Radiation Therapy for indolent lymphomas. This session will review clinical and practical updates in regards to dose considerations, patient selection and radiation techniques for this heterogenous group of patients. Considerations within a multi-disciplinary team environment will also be discussed.
learning objectives
- Differentiate patients that are appropriate for radiation therapy and which of these patients may benefit for ultra low dosing.
- Understand the toxicity reduction efforts with the various tools at our disposal including dose considerations and techniques.
Credits
| AMA PRA Category 1 Credits: | 1.25 |
Presentations
-
03:45pm - 05:00pm PT
Indolent Lymphomas: Radiation Oncology Considerations
Speaker: Sanjeev Aggarwal, MD - UVA Health Cancer Center, gainesville -
04:27pm - 04:37pm PT
Who and When - Indications for RT
Speaker: Ari Wijetunga, MD, PhD - University of North Carolina at Chapel Hill, Chapel Hill -
03:45pm - 03:47pm PT
Introductions
Speaker: Sanjeev Aggarwal, MD - UVA Health Cancer Center, gainesville -
03:47pm - 04:07pm PT
Nuts and Bolts of Indolent Lymphomas (clinicopathology, staging, prognosis)
Speaker: Yolanda Tseng, MD - University of Washington, Seattle -
04:07pm - 04:27pm PT
Toxicity Reduction Efforts with Radiation Therapy
Speaker: Chelsea Pinnix, MD, PhD - MD Anderson Cancer Center, Houston -
04:07pm - 04:27pm PT
Who and When - Indications for RT
Speaker: Joachim Yahalom, MD, FASTRO - Memorial Sloan Kettering Cancer Center, New York -
04:37pm - 04:50pm PT
Questions and Answers
Speaker: Sanjeev Aggarwal, MD - UVA Health Cancer Center, gainesville